OBJECTIVE: Endothelial dysfunction is linked to insulin resistance, inflammatory activation, and increased cardiovascular risk in diabetes mellitus; however, the mechanisms remain incompletely understood. Recent studies have identified proinflammatory signaling of wingless-type family member (Wnt) 5a through c-jun N-terminal kinase (JNK) as a regulator of metabolic dysfunction with potential relevance to vascular function. We sought to gain evidence that increased activation of Wnt5a-JNK signaling contributes to impaired endothelial function in patients with diabetes mellitus. APPROACH AND RESULTS: We measured flow-mediated dilation of the brachial artery and characterized freshly isolated endothelial cells by protein expression, eNOS activation, and nitric oxide production in 85 subjects with type 2 diabetes mellitus (n=42) and age- and sex-matched nondiabetic controls (n=43) and in human aortic endothelial cells treated with Wnt5a. Endothelial cells from patients with diabetes mellitus displayed 1.3-fold higher Wnt5a levels (P=0.01) along with 1.4-fold higher JNK activation (P<0.01) without a difference in total JNK levels. Higher JNK activation was associated with lower flow-mediated dilation, consistent with endothelial dysfunction (r=0.53, P=0.02). Inhibition of Wnt5a and JNK signaling restored insulin and A23187-mediated eNOS activation and improved nitric oxide production in endothelial cells from patients with diabetes mellitus. In endothelial cells from nondiabetic controls, rWnt5a treatment inhibited eNOS activation replicating the diabetic endothelial phenotype. In human aortic endothelial cells, Wnt5a-induced impairment of eNOS activation and nitric oxide production was reversed by Wnt5a and JNK inhibition. CONCLUSIONS: Our findings demonstrate that noncanonical Wnt5a signaling and JNK activity contribute to vascular insulin resistance and endothelial dysfunction and may represent a novel therapeutic opportunity to protect the vasculature in patients with diabetes mellitus.
OBJECTIVE:Endothelial dysfunction is linked to insulin resistance, inflammatory activation, and increased cardiovascular risk in diabetes mellitus; however, the mechanisms remain incompletely understood. Recent studies have identified proinflammatory signaling of wingless-type family member (Wnt) 5a through c-jun N-terminal kinase (JNK) as a regulator of metabolic dysfunction with potential relevance to vascular function. We sought to gain evidence that increased activation of Wnt5a-JNK signaling contributes to impaired endothelial function in patients with diabetes mellitus. APPROACH AND RESULTS: We measured flow-mediated dilation of the brachial artery and characterized freshly isolated endothelial cells by protein expression, eNOS activation, and nitric oxide production in 85 subjects with type 2 diabetes mellitus (n=42) and age- and sex-matched nondiabetic controls (n=43) and in human aortic endothelial cells treated with Wnt5a. Endothelial cells from patients with diabetes mellitus displayed 1.3-fold higher Wnt5a levels (P=0.01) along with 1.4-fold higher JNK activation (P<0.01) without a difference in total JNK levels. Higher JNK activation was associated with lower flow-mediated dilation, consistent with endothelial dysfunction (r=0.53, P=0.02). Inhibition of Wnt5a and JNK signaling restored insulin and A23187-mediated eNOS activation and improved nitric oxide production in endothelial cells from patients with diabetes mellitus. In endothelial cells from nondiabetic controls, rWnt5a treatment inhibited eNOS activation replicating the diabetic endothelial phenotype. In human aortic endothelial cells, Wnt5a-induced impairment of eNOS activation and nitric oxide production was reversed by Wnt5a and JNK inhibition. CONCLUSIONS: Our findings demonstrate that noncanonical Wnt5a signaling and JNK activity contribute to vascular insulin resistance and endothelial dysfunction and may represent a novel therapeutic opportunity to protect the vasculature in patients with diabetes mellitus.
Authors: José J Fuster; María A Zuriaga; Doan Thi-Minh Ngo; Melissa G Farb; Tamar Aprahamian; Terry P Yamaguchi; Noyan Gokce; Kenneth Walsh Journal: Diabetes Date: 2014-10-28 Impact factor: 9.461
Authors: Karly C Sourris; Jasmine G Lyons; Maximilian P J de Courten; Sonia L Dougherty; Darren C Henstridge; Mark E Cooper; Michelle Hage; Anthony Dart; Bronwyn A Kingwell; Josephine M Forbes; Barbora de Courten Journal: Diabetes Date: 2009-03-03 Impact factor: 9.461
Authors: Jessica L Fetterman; Monica Holbrook; Nir Flint; Bihua Feng; Rosa Bretón-Romero; Erika A Linder; Brittany D Berk; Mai-Ann Duess; Melissa G Farb; Noyan Gokce; Orian S Shirihai; Naomi M Hamburg; Joseph A Vita Journal: Atherosclerosis Date: 2016-02-13 Impact factor: 5.162
Authors: T Dylan Olver; Zachary I Grunewald; Thomas J Jurrissen; Rebecca E K MacPherson; Paul J LeBlanc; Teagan R Schnurbusch; Alana M Czajkowski; M Harold Laughlin; R Scott Rector; Shawn B Bender; Eric M Walters; Craig A Emter; Jaume Padilla Journal: Am J Physiol Regul Integr Comp Physiol Date: 2017-12-04 Impact factor: 3.619
Authors: Zachary I Grunewald; Francisco I Ramirez-Perez; Makenzie L Woodford; Mariana Morales-Quinones; Salvador Mejia; Camila Manrique-Acevedo; Ulrich Siebenlist; Luis A Martinez-Lemus; Bysani Chandrasekar; Jaume Padilla Journal: Hypertension Date: 2020-08-24 Impact factor: 10.190
Authors: Han Zhou; Sameet Mehta; Swayam Prakash Srivastava; Kariona Grabinska; Xinbo Zhang; Chris Wong; Ahmad Hedayat; Paola Perrotta; Carlos Fernández-Hernando; William C Sessa; Julie E Goodwin Journal: JCI Insight Date: 2020-02-13
Authors: Melissa G Farb; Shakun Karki; Song-Young Park; Samantha M Saggese; Brian Carmine; Donald T Hess; Caroline Apovian; Jessica L Fetterman; Rosa Bretón-Romero; Naomi M Hamburg; José J Fuster; María A Zuriaga; Kenneth Walsh; Noyan Gokce Journal: Vasc Med Date: 2016-09-28 Impact factor: 3.239